Sanara MedTech (SMTI) Non-Current Deffered Revenue (2017)

Sanara MedTech (SMTI) reported Non-Current Deffered Revenue of $14138.0 for Q3 2017, down 1.51% quarter-over-quarter from $14355.0 in Q2 2017.

Sanara MedTech (SMTI) Non-Current Deffered Revenue (2017) Analysis & Trends

Sanara MedTech has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $14138.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 163.15 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 11.80 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 208.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Sanara MedTech 196.68 Mn 183.08 Mn 25.87 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 14,138.00
Jun 30, 2017 14,355.00